1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
5.1.1.2. Increasing focus on early and primary intervention of heart-related disorders
5.1.1.3. Surge in geriatric population globally
5.1.2. Restraints
5.1.2.1. Relatively expensive devices and preference for drugs
5.1.3. Opportunities
5.1.3.1. Emerging adoption rate of these devices globally
5.1.3.2. Technological advancements in CHF treatment devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory approval process
5.2. Cumulative Impact of COVID-19

6. Congestive Heart Failure Treatment Device Market, by Product
6.1. Introduction
6.2. Cardiac Resynchronization Therapy
6.2.1. Cardiac Resynchronization Therapy-Defibrillator
6.2.2. Cardiac Resynchronization Therapy-Pacemaker
6.3. Implantable Cardioverter Defibrillator
6.3.1. Subcutaneous Implantable Cardioverter Defibrillator
6.3.2. Transvenous Implantable Cardioverter Defibrillator
6.4. Pacemaker
6.5. Ventricular Assist Device
6.5.1. Biventricular Assist Device
6.5.2. Left Ventricular Assist Device
6.5.3. Right Ventricular Assist Device

7. Congestive Heart Failure Treatment Device Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgery Center
7.3. Hospitals & Clinics

8. Americas Congestive Heart Failure Treatment Device Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Congestive Heart Failure Treatment Device Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Congestive Heart Failure Treatment Device Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abiomed, Inc.
12.2. Berlin Heart GmbH
12.3. Biotronik SE & Co. KG
12.4. Boston Scientific Corporation
12.5. HeartWare International, Inc.
12.6. Jarvik Heart, Inc.
12.7. LivaNova PLC
12.8. Medtronic plc
12.9. ReliantHeart Inc.
12.10. St. Jude Medical, Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PACEMAKER, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 29. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2027
FIGURE 31. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 35. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: SCORES
TABLE 49. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: RANKING
TABLE 52. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET: LICENSE & PRICING

Companies Mentioned

Abiomed, Inc.
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International, Inc.
Jarvik Heart, Inc.
LivaNova PLC
Medtronic plc
ReliantHeart Inc.
St. Jude Medical, Inc.